Is AstraZeneca Plc A Good Way To Play Emerging Markets?

On a current yield of 5.3%, does AstraZeneca have what it takes to make it into our special report “5 Shares To Retire On“? To find out the names of the five shares, and the reasons behind their inclusion, simply click here to have it delivered free to your inbox.

In this video series, Owain Bennallack take a look at some of the best routes within the FTSE 100 to gain from the growth of emerging markets. Under the spotlight this time is AstraZeneca (LSE: AZN) (NYSE: AZN.US).

> Owain does not own shares in AstraZeneca.